HEPATITIS B ENVELOPE ANTIGEN (HBEAG)/HEPATITIS B ENVELOPE ANTIBODY(ANTIHBE)

The Hepatitis B e Antigen (HBeAg) & Hepatitis B e Antibody (Anti-HBe) Test is a laboratory blood test that simultaneously evaluates HBeAg and Anti-HBe antibodies to assess the stage, activity, and infectivity of Hepatitis B Virus (HBV) infection. This combined test is an important part of the complete Hepatitis B serological profile and helps healthcare providers monitor disease progression and treatment response.

Hepatitis B is a viral infection that attacks the liver and spreads through infected blood, body fluids, sexual contact, contaminated needles, and from an infected mother to her baby during childbirth. The infection may be acute or chronic. Chronic hepatitis B requires long-term monitoring because it may progress to cirrhosis, liver failure, or hepatocellular carcinoma (liver cancer).

The HBeAg is a viral protein produced during active HBV replication. A positive HBeAg result usually indicates high levels of viral replication and increased infectivity, meaning the virus is more likely to spread to others.

The Anti-HBe antibody develops when the immune system produces antibodies against HBeAg. In many patients, HBeAg disappears and Anti-HBe becomes positive, a process called HBeAg seroconversion. This often indicates reduced viral replication and lower infectivity. However, some patients develop HBeAg-negative chronic hepatitis B, where viral replication continues despite a positive Anti-HBe result. Therefore, interpretation always requires additional laboratory testing.

The HBeAg/Anti-HBe Test is commonly performed together with:

• Hepatitis B Surface Antigen (HBsAg)
• Hepatitis B Surface Antibody (Anti-HBs)
• Total Anti-HBc
• Anti-HBc IgM
• HBV DNA (PCR)
• Liver Function Tests (LFTs)

Together, these investigations help determine disease activity, infectivity, immune response, and the effectiveness of antiviral treatment.

Benefits of the Test

• Evaluates active HBV replication.
• Assesses viral infectivity.
• Monitors immune response during hepatitis B infection.
• Helps determine disease stage.
• Supports monitoring of antiviral treatment.
• Assists in evaluating HBeAg seroconversion.
• Requires only a simple blood sample.
• Provides reliable laboratory results using validated immunoassay methods.

Why Doctors Recommend This Test

Doctors recommend the HBeAg & Anti-HBe Test to evaluate the stage of hepatitis B infection, monitor viral replication, assess infectivity, follow treatment response, and identify HBeAg seroconversion. The test plays a vital role in managing patients with chronic hepatitis B.

Preparation Before the Test

No special preparation is required.

You may eat and drink normally unless instructed otherwise by your healthcare provider. Inform your doctor about previous hepatitis B infection, antiviral treatment, liver disease, vaccination history, or medications. A blood sample is collected from a vein for laboratory analysis.

Normal Reporting Time

Typically: 1–3 Working Days

Reporting time may vary depending on laboratory methodology.

Who Should Take This Test?

This test is recommended for:

• Individuals diagnosed with hepatitis B.
• Patients with chronic HBV infection.
• People receiving antiviral therapy.
• Patients requiring HBV monitoring.
• Individuals with abnormal liver function tests.
• Pregnant women with hepatitis B.
• Healthcare workers exposed to HBV.
• Organ transplant candidates.
• Patients referred by hepatologists or infectious disease specialists.
• Anyone advised by their healthcare provider.